Eptifibatide did not significantly reduce the rate of adverse events in patients undergoing percutaneous coronary revascularization

Research output: Contribution to journal › Literature review › peer-review

Original language	English
Pages (from-to)	100-1
Number of pages	2
Journal	Evidence-based Cardiovascular Medicine
Volume	1
Issue number	4
DOIs	https://doi.org/10.1016/S1361-2611(97)80013-9
Publication status	Published - Dec 1997

Access to Document

@article{c575f84b04df4360b5aeada4c10c74ae,

title = "Eptifibatide did not significantly reduce the rate of adverse events in patients undergoing percutaneous coronary revascularization",

author = "Fox, {Keith A}",

note = "Copyright {\textcopyright} 1997 Published by Elsevier Ltd.",

year = "1997",

month = dec,

doi = "10.1016/S1361-2611(97)80013-9",

language = "English",

volume = "1",

pages = "100--1",

journal = "Evidence-based Cardiovascular Medicine",

issn = "1361-2611",

publisher = "Churchill Livingstone",

number = "4",

}

TY - JOUR

T1 - Eptifibatide did not significantly reduce the rate of adverse events in patients undergoing percutaneous coronary revascularization

AU - Fox, Keith A

PY - 1997/12

Y1 - 1997/12

U2 - 10.1016/S1361-2611(97)80013-9

DO - 10.1016/S1361-2611(97)80013-9

M3 - Literature review

VL - 1

SP - 100

EP - 101

JO - Evidence-based Cardiovascular Medicine

JF - Evidence-based Cardiovascular Medicine

SN - 1361-2611

IS - 4

ER -